BlackRock Fund Advisors’s Cogentix Medical, Inc. CGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$15K Buy
7,250
+1,620
+29% +$3.31K ﹤0.01% 3924
2016
Q3
$10K Sell
5,630
-22,410
-80% -$29K ﹤0.01% 3969
2016
Q2
$27K Sell
28,040
-46,112
-62% -$45.5K ﹤0.01% 3884
2016
Q1
$82K Sell
74,152
-5,896
-7% -$6.62K ﹤0.01% 3711
2015
Q4
$103K Buy
80,048
+2,696
+3% +$3.69K ﹤0.01% 3723
2015
Q3
$96K Sell
77,352
-2,046
-3% -$3.14K ﹤0.01% 3713
2015
Q2
$129K Buy
+79,398
New +$130K ﹤0.01% 3678

Other funds holding CGNT

BlackRock Fund Advisors's CGNT Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Cogentix Medical, Inc. (CGNT) stake by 29% in Q4 2016, buying an estimated $3.31K and bringing the position to 7,250 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #3924.

BlackRock Fund Advisors first reported a position in CGNT in Q2 2015 and has held it in 7 quarters since. The position peaked at $129K in Q2 2015. 37 funds tracked by Wall St. Rank hold CGNT as of Q4 2016.

  • BlackRock Fund Advisors held 7,250 shares of Cogentix Medical, Inc. worth $15K as of Q4 2016.
  • BlackRock Fund Advisors bought 1,620 Cogentix Medical, Inc. shares in Q4 2016, an estimated $3.31K.
  • Cogentix Medical, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3924 holding.
  • BlackRock Fund Advisors first reported a position in Cogentix Medical, Inc. in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Fund Advisors's Cogentix Medical, Inc. position peaked at $129K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.